Where I see patients (1)
My reviews
Selected research
-
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts.
Blood advances
-
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Leukemia
-
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Leukemia & lymphoma
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9